Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion type Assertion NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_head.
- NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion description "[Moreover, GATA5 CGI methylation could serve as a biomarker for tumour progression, although prospective and functional investigations are necessary to clarify whether independent information for future clinical management of patients with RCC can be obtained.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_provenance.
- NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion evidence source_evidence_literature NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_provenance.
- NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion SIO_000772 22289415 NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_provenance.
- NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion wasDerivedFrom befree-20150227 NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_provenance.
- NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_assertion wasGeneratedBy ECO_0000203 NP973003.RAhn5GLHinmnxMw01tqN3VZccCKSaUY5jnsJdYZvhkZXU130_provenance.